VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $3,844,000 | +39.9% | 165,424 | -4.2% | 0.96% | +37.2% |
| Q1 2018 | $2,748,000 | -14.2% | 172,600 | +12.0% | 0.70% | +0.9% |
| Q4 2017 | $3,202,000 | +2.8% | 154,100 | -29.1% | 0.69% | -2.9% |
| Q3 2017 | $3,114,000 | -22.6% | 217,300 | -6.5% | 0.71% | -21.5% |
| Q2 2017 | $4,022,000 | +71.7% | 232,500 | +9.5% | 0.91% | +73.3% |
| Q1 2017 | $2,342,000 | -22.6% | 212,300 | +1.9% | 0.52% | -36.3% |
| Q4 2016 | $3,024,000 | +24.3% | 208,300 | +110.2% | 0.82% | +21.1% |
| Q3 2016 | $2,433,000 | +7.3% | 99,100 | -12.0% | 0.68% | -2.9% |
| Q2 2016 | $2,267,000 | +95.9% | 112,600 | +155.9% | 0.70% | +113.1% |
| Q1 2016 | $1,157,000 | +48.7% | 44,000 | +1157.1% | 0.33% | +58.5% |
| Q2 2015 | $778,000 | – | 3,500 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |